MUCOPOLYSACCHARIDOSIS VI
Clinical trials for MUCOPOLYSACCHARIDOSIS VI explained in plain language.
Never miss a new study
Get alerted when new MUCOPOLYSACCHARIDOSIS VI trials appear
Sign up with your email to follow new studies for MUCOPOLYSACCHARIDOSIS VI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an arthritis drug ease pain in rare MPS diseases?
Symptom relief OngoingThis study tests whether adalimumab, a drug used for arthritis, can reduce pain and improve joint movement in people with MPS I, II, or VI. It includes 14 children and adults who have significant pain and limited joint motion. Participants receive either adalimumab or a placebo f…
Matched conditions: MUCOPOLYSACCHARIDOSIS VI
Phase: PHASE1, PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
New york babies to get extra screening for rare diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study offers parents of newborns in select New York hospitals the option to screen their baby for a panel of rare genetic disorders, beyond standard newborn screening. The goal is to learn how accurate the tests are, how common these conditions are, and whether early diagnos…
Matched conditions: MUCOPOLYSACCHARIDOSIS VI
Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 08:56 UTC